Fujirebio Europe is a renowned brand and a trusted partner to the diagnostics industry. As an R&D-driven company, they are continuously developing new technologies and unique biomarkers with high clinical value. Their mission is to create new value in healthcare and contribute to human health and the future of medical care.

With global teams located in Japan, Asia, Europe, and the US, Fujirebio focuses on delivering products of the highest quality standards to their customers and partners. With a heritage of innovation since 1950, Fujirebio has pioneered ground-breaking in vitro diagnostics testing solutions. Their product lines encompass specialized manual and automated testing, routine testing solutions, gold standard assays in neurodegeneration, infectious disease, oncology, and biomarkers for other diseases including SARS-CoV-2 infection.

With certified compliance in ISO standards, Fujirebio ensures their products are of the highest quality. Fujirebio Europe is committed to sustainability and social responsibility, actively implementing an Environmental Management System (EMS) to reduce their environmental impact. Their aim is to comply with legal requirements, reduce paper use, energy consumption, CO2 emissions during transport, and the use of hazardous materials.

With their commitment to environmental care and safe workplaces, Fujirebio Europe is a flexible and reliable business partner for diagnostic solutions